Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-04 Sale | 2026-03-05 7:14 pm | LeonaBio Inc. | LONA | Litton Mark James PRESIDENT and CEO | 5,156 | $5.37 | $27,688 | 59,894 (Indirect Direct) | View |
| 2026-03-04 Sale | 2026-03-05 7:10 pm | LeonaBio Inc. | LONA | Renninger Robert CHIEF FINANCIAL OFFICER | 906 | $5.37 | $4,865 | 15,851 (Direct) | View |
| 2026-03-04 Sale | 2026-03-05 7:06 pm | LeonaBio Inc. | LONA | Worthington Mark GENERAL COUNSEL and CCO | 1,328 | $5.37 | $7,131 | 18,376 (Direct) | View |
| 2026-03-04 Sale | 2026-03-05 7:02 pm | LeonaBio Inc. | LONA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 1,359 | $5.37 | $7,298 | 25,178 (Direct) | View |
| 2026-03-04 Sale | 2026-03-05 6:59 pm | LeonaBio Inc. | LONA | San Martin Javier CHIEF MEDICAL OFFICER | 1,720 | $5.37 | $9,236 | 15,887 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 7:52 pm | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 1,644 | $6.88 | $11,311 | 10,189 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 7:51 pm | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 2,586 | $6.88 | $17,792 | 42,796 (Indirect Direct) | View |
| 2026-01-02 Sale | 2026-01-05 7:50 pm | Athira Pharma Inc. | ATHA | Renninger Robert Chief Financial Officer | 297 | $6.88 | $2,043 | 12,857 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 7:50 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 876 | $6.88 | $6,027 | 20,681 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 7:49 pm | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 876 | $6.88 | $6,027 | 13,978 (Direct) | View |
| 2025-07-01 Sale | 2025-07-02 4:35 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 8,526 | $0.2935 | $2,502 | 205,568 (Direct) | View |
| 2025-07-01 Sale | 2025-07-02 4:34 pm | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 25,123 | $0.2935 | $7,374 | 453,824 (Indirect Direct) | View |
| 2025-07-01 Sale | 2025-07-02 4:33 pm | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 10,842 | $0.2935 | $3,182 | 118,332 (Direct) | View |
| 2025-07-01 Sale | 2025-07-02 4:33 pm | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 8,526 | $0.2935 | $2,502 | 148,542 (Direct) | View |
| 2025-07-01 Sale | 2025-07-02 4:32 pm | Athira Pharma Inc. | ATHA | Renninger Robert SVP, Finance and Accounting | 2,897 | $0.2935 | $850 | 121,545 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-09 Option Award | 2026-04-13 4:59 pm | N/A 2036-04-08 | LeonaBio Inc. | LONA | Panzara Michael A. Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-13 4:58 pm | N/A 2036-04-08 | LeonaBio Inc. | LONA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 300,000 | $0 | 300,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-13 4:56 pm | N/A 2036-04-08 | LeonaBio Inc. | LONA | Kosacz Barbara Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-13 4:55 pm | N/A 2036-04-08 | LeonaBio Inc. | LONA | PICKERING GRANT Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-13 4:54 pm | N/A 2036-04-08 | LeonaBio Inc. | LONA | Romano Kelly A Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-13 4:53 pm | N/A 2036-04-08 | LeonaBio Inc. | LONA | JOHNSON JAMES A Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-13 4:52 pm | N/A 2036-04-08 | LeonaBio Inc. | LONA | EDELMAN JOSEPH Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-13 4:51 pm | N/A 2036-04-08 | LeonaBio Inc. | LONA | San Martin Javier CHIEF MEDICAL OFFICER | 350,000 | $0 | 350,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-13 4:49 pm | N/A 2036-04-08 | LeonaBio Inc. | LONA | FLUKE JOHN M JR Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-13 4:48 pm | N/A 2036-04-08 | LeonaBio Inc. | LONA | Worthington Mark GENERAL COUNSEL and CCO | 300,000 | $0 | 300,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-13 4:47 pm | N/A 2036-04-08 | LeonaBio Inc. | LONA | Renninger Robert CHIEF FINANCIAL OFFICER | 300,000 | $0 | 300,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-13 4:46 pm | N/A 2036-04-08 | LeonaBio Inc. | LONA | Litton Mark James PRESIDENT and CEO | 750,000 | $0 | 750,000 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 7:14 pm | N/A N/A | LeonaBio Inc. | LONA | Litton Mark James PRESIDENT and CEO | 22,254 | $0 | 59,894 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 7:10 pm | N/A N/A | LeonaBio Inc. | LONA | Renninger Robert CHIEF FINANCIAL OFFICER | 3,900 | $0 | 15,851 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 7:06 pm | N/A N/A | LeonaBio Inc. | LONA | Worthington Mark GENERAL COUNSEL and CCO | 5,726 | $0 | 18,376 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 7:02 pm | N/A N/A | LeonaBio Inc. | LONA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 5,856 | $0 | 25,178 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 6:59 pm | N/A N/A | LeonaBio Inc. | LONA | San Martin Javier CHIEF MEDICAL OFFICER | 7,418 | $0 | 15,887 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 7:52 pm | N/A N/A | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 4,667 | $0 | 10,189 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 7:51 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 10,834 | $0 | 42,796 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 7:50 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert Chief Financial Officer | 1,236 | $0 | 12,857 (Direct) | View |
| 2025-11-18 Option Award | 2026-01-05 7:50 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert Chief Financial Officer | 1,000 | $2.31 | 12,857 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 7:50 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 3,667 | $0 | 20,681 (Direct) | View |
| 2025-11-18 Option Award | 2026-01-05 7:50 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 1,000 | $2.31 | 20,681 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 7:49 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 3,667 | $0 | 13,978 (Direct) | View |
| 2025-12-24 Option Award | 2025-12-29 4:19 pm | N/A 2035-09-23 | Athira Pharma Inc. | ATHA | Renninger Robert Chief Financial Officer | 34,358 | $0 | 34,358 (Direct) | View |
| 2025-12-24 Option Award | 2025-12-29 4:17 pm | N/A 2035-09-24 | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 133,526 | $0 | 133,526 (Direct) | View |
| 2025-12-24 Option Award | 2025-12-29 4:15 pm | N/A 2035-09-23 | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 35,138 | $0 | 35,138 (Direct) | View |
| 2025-12-24 Option Award | 2025-12-29 4:14 pm | N/A 2035-09-23 | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 44,508 | $0 | 44,508 (Direct) | View |
| 2025-12-24 Option Award | 2025-12-29 4:12 pm | N/A 2035-09-23 | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 34,358 | $0 | 34,358 (Direct) | View |
| 2025-12-23 Option Award | 2025-12-23 5:12 pm | N/A N/A | Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Perceptive Xontogeny Venture Fund II LP Director 10% Owner | 11,161,543 | $6.35 | 17,505,255 (Indirect) | View |
| 2025-12-23 Option Award | 2025-12-23 5:12 pm | 2025-12-23 N/A | Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Perceptive Xontogeny Venture Fund II LP Director 10% Owner | 1,830,580 | $6.349 | 17,505,255 (Indirect) | View |
| 2025-12-23 Option Award | 2025-12-23 5:12 pm | N/A N/A | Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Perceptive Xontogeny Venture Fund II LP Director 10% Owner | 5,502,402 | $0 | 17,505,255 (Indirect) | View |
| 2025-06-30 Exercise | 2025-07-02 4:35 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 36,666 | $0 | 205,568 (Direct) | View |
| 2025-05-19 Option Award | 2025-07-02 4:35 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 10,000 | $0.2312 | 205,568 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:34 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 108,334 | $0 | 453,824 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:33 pm | N/A N/A | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 46,666 | $0 | 118,332 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:33 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 36,666 | $0 | 148,542 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:32 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert SVP, Finance and Accounting | 12,359 | $0 | 121,545 (Direct) | View |
| 2025-05-19 Option Award | 2025-07-02 4:32 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert SVP, Finance and Accounting | 10,000 | $0.2312 | 121,545 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:37 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | FLUKE JOHN M JR Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:36 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | Panzara Michael A. Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:35 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | Romano Kelly A Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:34 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | EDELMAN JOSEPH Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:34 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | JOHNSON JAMES A Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:33 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | Kosacz Barbara Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:32 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | PICKERING GRANT Director | 20,900 | $0 | 20,900 (Direct) | View |